Metraipolis › archive › dc_b977fcdaafb6
MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer — Europe PMC PMID:41202504
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41202504
- DOI
- 10.1016/j.esmoop.2025.105840
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T18:23:20.320Z
- SHA-256 of the archived text
6b92c4227aa5ebada1b3f6fee669cf61e33fc961505f7605381a1516bc17bf32- Stable URL of this page
https://metraipolis.com/documento/dc_b977fcdaafb6
How to cite
MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer — Europe PMC PMID:41202504 — Europe PMC (en), https://europepmc.org/article/MED/41202504 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b977fcdaafb6 (Metraipolis archive dc_b977fcdaafb6, sha256 6b92c4227aa5ebada1b3f6fee669cf61e33fc961505f7605381a1516bc17bf32)
BibTeX
@misc{dcb977fcdaafb6,
title = {MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer — Europe PMC PMID:41202504},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41202504},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b977fcdaafb6; sha256 6b92c4227aa5ebada1b3f6fee669cf61e33fc961505f7605381a1516bc17bf32},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41202504. Agents can read the archived copy with the MCP tool read_document.